World's Best Scientists 2026 revealed!
Maria-Victoria Mateos

Maria-Victoria Mateos

D-Index & Metrics

Medicine

D-Index
100
Citations
50230
World Ranking
8150
National Ranking
117

Overview

Maria-Victoria Mateos is affiliated with the University of Salamanca in Spain and has an extensive publication record primarily focused on medicine and biochemistry, genetics, and molecular biology. Their research spans various subfields, particularly hematology, oncology, molecular biology, genetics, and radiology, nuclear medicine, and imaging.

The scientist's work centers mostly on multiple myeloma research and treatments, with significant contributions in protein degradation and inhibitors, peptidase inhibition and analysis, CAR-T cell therapy research, monoclonal and polyclonal antibodies research, cancer treatment and pharmacology, and chronic lymphocytic leukemia research.

Frequent coauthors collaborating with Maria-Victoria Mateos include Jesús F. San Miguel, Albert Oriol, Paula Rodríguez-Otero, Joaquin Martínez-López, and Philippe Moreau. These collaborations have led to numerous publications across renowned medical and oncology journals.

The most common publication venues for their work are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • HemaSphere
  • Blood Cancer Journal

Notable recent papers include:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (2022, Blood)
  • Teclistamab in Relapsed or Refractory Multiple Myeloma (2022, New England Journal of Medicine)
  • Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2021, Annals of Oncology)
  • Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma (2023, New England Journal of Medicine)
  • Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma (2022, New England Journal of Medicine)

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

    Jesús F. San Miguel;Rudolf Schlag;Nuriet K. Khuageva;Meletios A. Dimopoulos

  • Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

    Antonio Palumbo;Asher Chanan-Khan;Katja Christina Weisel;Ajay K Nooka

  • Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

    Sagar Lonial;Brendan M Weiss;Saad Z Usmani;Seema Singhal

  • Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

    María-Victoria Mateos;Meletios A. Dimopoulos;Michele Cavo;Kenshi Suzuki

  • Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Pieter Sonneveld;Hervé Avet-Loiseau;Sagar Lonial;Saad Usmani

  • Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P. Moreau;J. San Miguel;P. Sonneveld;M. V. Mateos

  • Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Antonio Palumbo;Sara Bringhen;Maria Victoria Mateos;Alessandra Larocca

  • New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

    Ernesto Pérez-Persona;María-Belén Vidriales;Gema Mateo;Ramón García-Sanz

  • Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

    María-Victoria Mateos;Miguel-Teodoro Hernández;Pilar Giraldo;Javier de la Rubia

  • Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

    María-Victoria Mateos;Albert Oriol;Joaquín Martínez-López;Norma Gutiérrez

  • Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

    Maria-Victoria Mateos;Paul G. Richardson;Rudolf Schlag;Nuriet K. Khuageva

  • Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.

    Laura Rosiñol;Albert Oriol;Ana Isabel Teruel;Dolores Hernández

  • Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

    María-Victoria Mateos;María-Victoria Mateos;José-M. Hernández;José-M. Hernández;Miguel-T. Hernández;Miguel-T. Hernández;Norma-C. Gutiérrez;Norma-C. Gutiérrez

  • Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.

    Bruno Paiva;Maria-Belén Vidriales;Jorge Cerveró;Gema Mateo

  • Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

    Joaquin Martinez-Lopez;Juan J. Lahuerta;François Pepin;Marcos González

  • Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

    María-Victoria Mateos;Albert Oriol;Joaquín Martínez-López;Norma Gutiérrez

Frequent Co-Authors

Albert Oriol
Albert Oriol Autonomous University of Barcelona
Joan Bladé
Joan Bladé University of Barcelona
Jesús F. San Miguel
Jesús F. San Miguel University of Navarra
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Michele Cavo
Michele Cavo University of Bologna
Ramón García-Sanz
Ramón García-Sanz University of Salamanca
Paul G. Richardson
Paul G. Richardson Harvard University
Philippe Moreau
Philippe Moreau University of Nantes
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond traditional medical school, there are diverse, flexible pathways for those interested in healthcare careers in the USA. Many opt to start with nursing, where options such as cheap rn to bsn online programs let registered nurses advance their qualifications affordably and conveniently. These programs can help you take on more responsibilities, higher pay, and leadership roles.

If you hold a non-nursing bachelor’s degree, direct entry msn programs for non-nursing majors can provide a fast track to an advanced nursing career, bypassing the need for a second undergraduate degree. Entry requirements for healthcare programs also vary—if admission competitiveness is a concern, find what is the easiest nursing school to get into to increase your chances of acceptance.

For those interested in the administrative side of healthcare, earning a credential through one of the accredited medical billing and coding schools with financial aid can open doors to in-demand office-based roles without the need for years of medical training.

Best Scientists Citing Maria-Victoria Mateos

Trending Scientists

Recently Published Articles